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ABSTRACT
Introduction: The need for defining the extension of disease in patients undergoing radical
prostatectomy due to prostate adenocarcinoma is a relevant factor cure in such individuals. In order to
identify a new independent preoperative factor for predicting the extension of prostate cancer, we
assessed the role of the percentage of positive fragments upon biopsy.
Materials and Methods: A retrospective study compared the percentage of positive frag-
ments on biopsy with the extension of disease as defined by the pathological examination of the
surgical specimen from 898 patients undergoing radical prostatectomy due to clinically localized
prostate cancer.
Results: On the univariate analysis, the percentage of positive fragments on biopsy showed a
statistical significance for predicting confined disease (p < 0.001), which was found in 66.7% of the
cases under study. Additionally, we observed that the total number of removed fragments exerts no
influence on the extension of the disease (p = 0.567).
Conclusion: the percentage of positive fragments is an independent factor for predicting the
pathological stage of prostate adenocarcinoma, and the number of removed fragments is not related to
the extension of the disease.
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INTRODUCTION
According to data from the National Cancer
Institute at the Ministry of Health, between 1979 and
2000 there was an increase of 141% in mortality due
to prostate adenocarcinoma in Brazil, making this dis-
ease the second cause of death from tumors in males,
second only to lung cancer. Prostate cancer also rep-
resents the second most prevalent malignant neo-
plasm, behind skin cancer. In 2003 in Brazil, 35,240
new cases were predicted, with 8230 deaths due to
prostate adenocarcinoma (1). These figures are ap-
proximately 10 times lower than those estimated for
the United States of America by the National Cancer
Institute, where prostate cancer was responsible for
10% of deaths from malignant neoplasms in 2004,
second only to lung cancer (2).
Among the available treatments in cases of
localized prostate adenocarcinoma, the most fre-
quently performed is radical prostatectomy, which is
used in 52% of patients, followed by external radio-
therapy or brachytherapy, which is used in approxi-
mately 20% of patients (3).
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The great challenge in clinical practice is to
perform an accurate early diagnosis of confined dis-
ease, since in more than 30% of cases judged as local-
ized, the subsequent pathological study shows more
advanced disease than was initially expected (4).
Aiming to clinically define the presence of
localized disease, and thus, the feasibility for cura-
tive treatment, most experts consider especially the
initial PSA levels, the tumor extension upon digital
rectal examination and the degree of neoplastic dif-
ferentiation as assessed by the Gleason score (5). New
parameters for predicting the chances of disease re-
currence and the presence of organ-confined tumors
have also been studied (6,7), including the number of
fragments positive to cancer on biopsy, which seems
to represent an independent prognostic factor (8).
Considering that the percentage of fragments
involved by tumor on biopsy represents an important
prognostic factor (6,9), we devised the present study,
which intends to analyze the preoperative predictive
role of the percentage of positive fragments upon bi-
opsy for predicting the extension of disease.
MATERIALS AND METHODS
We retrospectively analyzed 960 patients di-
agnosed with localized prostate cancer undergoing
retropubic radical prostatectomy whose medical
charts recorded the total number of biopsied frag-
ments, the number of fragments with cancer, the
Gleason score on biopsy, the serum PSA levels and
the pathological exam of the surgical specimen. Fifty-
four patients who had received neoadjuvant treatment
were excluded, as were 8 patients whose diagnosis
was obtained by endoscopic resection of the prostate
or transvesical prostatectomy, thus totaling 62 ex-
cluded cases and 898 inclusions. Patient ages ranged
from 40 to 83 years, with a mean age of 62.9 years.
The clinical staging (Table-1) used the TNM
classification (10). For this purpose, auxiliary exami-
nations were performed, including digital rectal ex-
amination, transrectal ultrasound of the prostate,
abdominal and pelvic computerized tomography or
magnetic resonance imaging, bone scintigraphy and
thorax radiography.
Patients underwent retropubic radical pros-
tatectomy with bilateral selective iliac lymphadenec-
tomy. All interventions were performed by the same
surgeon (MS).
All surgical specimens consisting of the pros-
tate, seminal vesicles and obturator lymph nodes were
assessed by the same pathology (KML).
The specimens were fixed in 10% formol for
approximately 6 hours and underwent a routine starting
with measuring and weighing the gland. Thin transver-
sal sections were performed on the surgical margins rela-
tive to the bladder neck and the prostate apex. Using the
urethra as a reference, the remaining gland was immersed
in India ink stain and then sequentially sliced each 3
millimeters. 8 to 10 sections from each lobe were in-
cluded for histological examination. Seminal vesicles
were sectioned at the base and prepared for histologi-
cal examination following longitudinal sectioning. Ob-
turator lymph nodes were dissected and sliced in order
to go through pathological examination.
Following the usual preparation in paraffin,
the sections were stained by HE and analyzed under
binocular light microscope. Parameters assessed were:
Infiltration of periprostatic tissue – Peripros-
tatic involvement was defined as the neoplastic inva-
sion of fat tissue and periprostatic neurovascular
plexus. In such cases, the disease was classified as
non-confined.
Infiltration of seminal vesicles – The involve-
ment of seminal vesicles was considered only when
their parenchyma – and not the adventitial region –
was involved in the tumor.
Metastases to lymph nodes – Obturator lymph
nodes that were involved by tumor were classified as
having metastases.
Table 1 – Patient distribution according to clinical stage.
Clinical  Stage   N (%)
T1c 432 (48)
T2a 218 (24.3)
T2b 173 (19.3)
T2c 068 (7.6)
T3a 007 (0.8)
Total 898 (100.0)
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Postoperative pathological staging – the TNM
staging system was used for the final analysis (10).
The distribution of patients under study is reported
in Table-2.
The frequency of organ-confined disease,
periprostatic extension and invasion of seminal
vesicles was compared with the percentage of posi-
tive fragments. For this purpose, the percentage of
positive fragments was divided into four categories:
0 - 25%; 25.1 - 50%; 50.1 - 75% and 75.1 - 100%. We
also divided the number of fragments collected on
biopsy into 3 categories: less than 6; 6; and more than
6, and compared them with the extension of disease.
Statistical Analysis
In order to compare the percentages of posi-
tive fragments on biopsy with confined or non-con-
fined disease, we used the Pearson’s Qui-Square test
(univariate analysis). For comparing the mean per-
centage of positive fragments on biopsy with con-
fined or non-confined disease, we used the student’s
t test following the analysis of distribution normality
for percentages of positive fragments. A significance
level of 5% was adopted, with results being consid-
ered as statistically significant when they showed
p < 0.05.
RESULTS
Figure-1 shows that the number of fragments
removed on biopsy did not interfere with the patho-
Table 2 –  Patient distribution according to postoperative
pathological stage.
  N  (%)
194 (21.6)
168 (18.7)
237 (26.4)
182 (20.3)
001 (0.1)
011 (1.2)
095 (10.6)
007 (0.8)
001 (0.1)
002 (0.2)
898 (100.0)
Pathological Stage
T2a
T2b
T2c
T3a
T3a/N+
T3b
T3c
T3c/N+
T4a
T4a/N+
Total
Figure 1 – Distribution of total number of collected fragments and distribution of lesions identified on biopsy.
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logical results of surgical specimens (p = 0.567), thus
evidencing the uniformity of cases under study.
Figure-2 compares the percentage of positive
fragments and the presence of organ-confined disease.
According to the data obtained in the study, there is a
positive association between the percentage of posi-
tive fragments on biopsy and the stage of disease
(p < 0.001).
Table-3 compares the mean percentage of
positive fragments between confined and non-con-
fined disease. The percentage of positive fragments
on average is 9.72% (± 1.68) higher in patients with
non-confined disease (p < 0.001).
Table-4 shows that regardless of results from
the surgical specimen, approximately 55% of patients
had more than six fragments removed.
In Table-5 we can see that regardless of re-
sults from the surgical specimen, the average of col-
lected fragments was 8 ± 3, with a minimum of 2 and
a maximum of 22 fragments removed on biopsy.
We can see in Table-6 that regardless of results
from the surgical specimens, the average of positive frag-
ments was 3.2 ± 2.1, with the minimal number of posi-
tive fragments being one and the maximal 20.
COMMENTS
In our study, 66.7% of patients had neoplasm
confined to the gland following radical prostatectomy,
with this figure ranging from 13 to 82% (11,12). This
variation depends mainly on Gleason score, PSA,
Figure 2 – Distribution of percentage of positive fragments according to the extension of prostate cancer.
Table 3 – Descriptive measures for the percentage of af-
fected fragments on biopsy according to the presence of
confined or non-confined cancer.
Confined Non Confined
Mean 038% 047.7%
Standard deviation 022.7% 025.4%
Median 033.3% 050%
Minimum 005.3% 005%
Maximum 100.0% 100.0%
Total 601 297
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clinical stage and, currently, the percentage of posi-
tive fragments on biopsy.
D’Amico et al. (9) observed that the percent-
age of positive fragments on biopsy is an important
parameter for predicting confined disease, demon-
strating that when less than 34% of the fragments are
affected, 79% of the patients have gland-confined
disease, and when the number of affected fragments
is greater than 50%, only 43% have confined disease.
In our work, we observed that when there are less
than 25% of fragments affected by tumor, the chance
of confined disease is 75.5%, and only 43.9% of in-
dividuals with more than 75% of positive fragments
on biopsy have confined disease.
When comparing the percentage of fragments
involved in cancer with the possibility of involvement
of the seminal vesicles by the neoplasm, we verified
that when only one fragment has neoplasm, the risk
of seminal vesicles being positive to cancer is 6%;
however, when there are six fragments involved, this
risk raises to 83% (4). Our study revealed that in-
volvement of the seminal vesicles in 6.2% of patients
when less than 25% of fragments had cancer, versus
31.7% when more than 75% were affected.
Table 5 – Descriptive measures for total number of collected fragments according to tumor location.
Confined Extra-prostatic    Invasion of Total Number
   Extension Seminal Vesicle  of Fragments
Mean 008.17 008.13 007.97 008.14
Standard deviation 003.4 002.99 003.49 003.33
Median 007 006 006 007
Minimum 002 002 002 002
Maximum 022 019 022 022
Total 601 192 105 898
Table 4 –  Patient distribution according to the number of collected fragments and pathological result.
The importance of the number of positive
fragments on biopsy for predicting confined disease
is related to the number of positive fragments and the
results obtained with radical prostatectomy. When the
disease is confined, the average of positive fragments
is 35%, while in individuals with non-confined dis-
ease this average rises to 55% (7). In our work, we
found similar figures, with an average of 38% for con-
fined disease versus 47.7% for non-confined disease.
The percentage of positive fragments has a
linear relationship with tumor volume in the surgical
specimen (13). Additionally, for each 1% increase in
the affected fragments, the risk of non-confined dis-
ease increases by 2% (14).
In cases followed over 5 years, Epstein et al.
(15) observed that approximately 26% of patients with
less than 4 cc of tumor in the surgical specimen evi-
denced a recurrence of the disease and almost 50% of
patients with more than 4 cc had a progression in the
disease, thus demonstrating the importance of tumor
volume for the outcome of disease. Similarly, Stamey
et al. (16) confirmed the prognostic importance of tu-
mor volume and reported that 86% of patients with
volume between 0.5 and 2.0 cc did not experience a
N Fragments         Confined     Extra-prostatic                Invasion of                       Total Number
 Extension  Seminal Vesicle  of Fragments
< 6 050 (67.6%) 015 (20.3%) 009 (12.1%) 074 (8.2%)
6 224 (67.7%) 063 (19%) 044 (13.3%) 331 (36.9%)
> 6 327 (66.3%) 114 (23.1%) 052 (10.6%) 493 (54.9%)
Total 601 (66.9%) 192 (21.4%) 105 (11.7%) 898 (100.0%)
450
PCa  AND INVOLVED FRAGMENTS ON BIOPSY
Table 6 –  Descriptive measures for total number of fragments with cancer according to tumor location.
            Confined                    Extra-prostatic                    Invasion of              Total Number
        Extension                  Seminal Vesicle          of  Fragments
Mean 002.9 003.4 004.1 003.2
Standard deviation 002 002 002.5 002.1
Median 002 004 004 003
Minimum 001 001 001 001
Maximum 020 012 013 020
Total 601 192 105 898
progression of the disease, in opposition to patients
with more than 12 cc of tumor volume, of which 96%
evidenced a biochemical recurrence of the disease.
Upon understanding the importance of tumor volume
in relation to the risks of recurrence of disease, the
number of positive fragments on biopsy has been used
to predict the occurrence of non-confined disease and
recurrence following radical prostatectomy (9,17).
Nevertheless, some polemics involve the subject, since
some studies suggest that we should not consider the
percentage of positive fragments but the percentage of
cancer found in each fragment, which would be a more
accurate predictive factor (18). However, studies com-
paring the percentage of positive fragments on biopsy
with the percentage of tissue affected by cancer (14,19)
have demonstrated that both methods are strongly as-
sociated with the definition of non-confined disease
(20). Since the final result appears to be equal, and the
calculation of the area with cancer in the fragments is
more time-consuming and complex, it is advantageous
to use the percentage of positive fragments on biopsy
in the clinical practice.
Prostate adenocarcinoma is the third cause
of death from cancer in males in the world, and its
incidence and mortality are increasing in our coun-
try, due to the increase in life expectancy, improve-
ment and dissemination of diagnostics methods, and
unknown etiopathogenic factors. In order to improve
the accurate preoperative diagnosis of confined dis-
ease, we should intensify the studies on the param-
eters that should be used, thus allowing more effec-
tive interventions and, consequently, increasing the
chances of cure for patients with this disease. In this
context, the present study aimed to define and con-
solidate a new parameter that should be considered
for assessing the extension of disease preoperatively.
CONCLUSION
The percentage of positive fragments on bi-
opsy is an independent preoperative factor (univariate
analysis) for predicting the pathological stage of pros-
tate cancer in the surgical specimen, and the number
of fragments removed on biopsy has no influence on
the extension of disease.
Adriana Sanudo performed the statistical analysis.
REFERENCES
1. Brazil. Ministry of Health. National Cancer Institute.
Estimate of cancer and mortality for cancer in Brazil
2003. Available at: www.inca.gov.br/estimativas/2003.
Accessed on: 02/26/2004. [in Portuguese]
2. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels
A, Ward E, et al.: Cancer statistics, 2004. CA Cancer J
Clin. 2004; 54: 8-29.
3. Cooperberg MR, Broering JM, Litwin MS, Lubeck DP,
Mehta SS, Henning JM, et al.: The contemporary man-
agement of prostate cancer in the United States: les-
sons from the cancer of the prostate strategic urologic
research endeavor (CapSURE), a national disease reg-
istry. J Urol. 2004; 171: 1393-401.
4. Peller PA, Young DC, Marmaduke DP, Marsh WL,
Badalament RA: Sextant prostate biopsies. A histo-
pathologic correlation with radical prostatectomy
specimens. Cancer. 1995; 75: 530-8.
451
PCa  AND INVOLVED FRAGMENTS ON BIOPSY
5. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein
JI, Walsh PC: Biochemical (prostate specific antigen)
recurrence probability following radical prostatectomy
for clinically localized prostate cancer. J Urol. 2003;
169: 517-23.
6. Gancarczyk KJ, Wu H, McLeod DG, Kane C, Kusuda
L, Lance R, et al.: Using the percentage of biopsy
cores positive for cancer, pretreatment PSA, and high-
est biopsy Gleason sum to predict pathologic stage
after radical prostatectomy: the Center for Prostate
Disease Research nomograms. Urology. 2003; 61:
589-95.
7. Sebo TJ, Bock BJ, Cheville JC, Lohse C, Wollan P,
Zincke H: The percent of cores positive for cancer in
prostate needle biopsy specimens is strongly predic-
tive of tumor stage and volume at radical prostatec-
tomy. J Urol. 2000; 163: 174-8.
8. Grossfeld GD, Latini DM, Lubeck DP, Broering JM,
Li YP, Mehta SS, et al.: Predicting disease recurrence
in intermediate and high-risk patients undergoing radi-
cal prostatectomy using percent positive biopsies: re-
sults from CapSURE. Urology. 2002; 59: 560-5.
9. D’Amico AV, Whittington R, Malkowicz SB, Schultz
D, Fondurulia J, Chen MH, et al.: Clinical utility of
the percentage of positive prostate biopsies in defin-
ing biochemical outcome after radical prostatectomy
for patients with clinically localized prostate cancer. J
Clin Oncol. 2000; 18: 1164-72.
10. Schroder FH, Hermanek P, Denis L, Fair WR,
Gospodarowicz MK, Pavone-Macaluso M: The TNM
classification of prostate cancer. Prostate Suppl. 1992;
4: 129-38.
11. Partin AW, Yoo J, Carter HB, Pearson JD, Chan DW,
Epstein JI, et al.: The use of prostate specific antigen,
clinical stage and Gleason score to predict pathologi-
cal stage in men with localized prostate cancer. J Urol.
1993; 150: 110-4.
12. Freedland SJ, Csathy GS, Dorey F, Aronson WJ: Per-
cent prostate needle biopsy tissue with cancer is more
predictive of biochemical failure or adverse pathology
after radical prostatectomy than prostate specific anti-
gen or Gleason score. J Urol. 2002; 167: 516-20.
13. Rubin MA, Mucci NR, Manley S, Sanda M,
Cushenberry E, Strawderman M, et al.: Predictors of
Gleason pattern 4/5 prostate cancer on prostatectomy
specimens: can high grade tumor be predicted preop-
eratively? J Urol. 2001; 165: 114-8.
14. Sebo TJ, Cheville JC, Riehle DL, Lohse CM, Pankratz
VS, Myers RP, et al.: Predicting prostate carcinoma
volume and stage at radical prostatectomy by assess-
ing needle biopsy specimens for percent surface area
and cores positive for carcinoma, perineural invasion,
Gleason score, DNA ploidy and proliferation, and pre-
operative serum prostate specific antigen: a report of
454 cases. Cancer. 2001; 91: 2196-204.
15. Epstein JI, Carmichael M, Partin AW, Walsh PC: Is tu-
mor volume an independent predictor of progression fol-
lowing radical prostatectomy? A multivariate analysis of
185 clinical stage B adenocarcinomas of the prostate with
5 years of follow up. J Urol. 1993; 149: 1478-81.
16. Stamey TA, McNeal JE, Yemoto CM, Sigal BM,
Johnstone IM: Biological determinants of cancer pro-
gression in men with prostate cancer. JAMA. 1999;
281: 1395-400.
17. Ravery V, Chastang C, Toublanc M, Boccon-Gibod L,
Delmas V, Boccon-Gibod L: Percentage of cancer on
biopsy cores accurately predicts extracapsular exten-
sion and biochemical relapse after radical prostatec-
tomy for T1-T2 prostate cancer. Eur Urol. 2000; 37:
449-55.
18. Bostwick DG, Grignon DJ, Hammond ME, Amin MB,
Cohen M, Crawford D, et al.: Prognostic factors in
prostate cancer. College of American Pathologists
Consensus Statement 1999. Arch Pathol Lab Med.
2000; 124: 995-1000.
19. Linson PW, Lee AK, Doytchinova T, Chen MH,
Weinstein MH, Richie JP, et al.: Percentage of core
lengths involved with prostate cancer: does it add to
the percentage of positive prostate biopsies in predict-
ing postoperative prostate-specific antigen outcome for
men with intermediate-risk prostate cancer? Urology.
2002; 59: 704-8.
20. Ojea Calvo A, Nunez Lopez A, Dominguez Freire F,
Alonso Rodrigo A, Rodriguez Iglesias B, Benavente
Delgado J, et al.: Correlation of the anatomo-patho-
logical staging of radical prostatectomy specimens with
the amount of cancer in the preoperative sextant bi-
opsy. Actas Urol Esp. 2003; 27: 428-37.
Received: February 1, 2005
Accepted after revision: May 16, 2005
Correspondence address:
Dr. Marcos F. Dall’Oglio
Rua Barata Ribeiro, 398 / 501
São Paulo, SP, 01308-000, Brazil
Fax: + 55 11 3159-3618
E-mail: marcosdallogliouro@terra.com.br
